Recombinant Monkeypox virus/MPXV E8L Protein from ProteoGenix; catalogue PX-P6055; research use only.
Know who made it. See the evidence. Buy through one marketplace.
Recombinant Monkeypox Virus E8L Protein is a single polypeptide chain of 559 amino acids. It contains two domains, an N-terminal domain of approximately 250 amino acids and a C-terminal domain of approximately 300 amino acids.
Monkeypox Virus E8L Protein:ActivityRecombinant Monkeypox Virus E8L Protein is a viral protein that is expressed on the surface of infected cells. It plays a role in the pathogenesis of monkeypox by binding to the host cell surface and mediating virus-cell interactions.
Application of this antigenRecombinant Monkeypox Virus E8L Protein has potential applications in the development of vaccines and therapies against monkeypox. It is a promising drug target for the development of antiviral drugs and immunotherapies.
ProteoGenix catalogue number PX-P6055. For research use only.
Host: Mammalian cells; Expression system: Eukaryotic expression; Purity: >85% by SDS-PAGE; Molecular weight: 34.94 kDa; Tag: C-terminal His Tag; Fragment: Pro2-Lys274; Buffer: PBS, pH7.5; Applications: ELISA, WB.
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
